NTRK2 and cancer: BDNF activates tropomyosin-related receptor kinase B (TrkB), initiating critical signaling pathways such as RAS/MAPK, PI3K/Akt, and JAK2/STAT3, which influence cancer progression and affect cellular processes including proliferation and migration [90, 91].